Cariprazine and Nortriptyline: interaction and safety
This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.
Interaction mechanism
Nortriptyline may increase the sedative effects of other CNS depressants. Tricyclic antidepressant and neuroleptic co-treatment carries class warnings about metabolic interactions and a lower seizure threshold. Centrally acting medicines require caution because dizziness and mental or motor impairment may overlap.
Clinical significance and safety
Cariprazine and Nortriptyline: Nortriptyline may increase the sedative effects of other CNS depressants. Tricyclic antidepressant and neuroleptic co-treatment carries class warnings about metabolic interactions and a lower seizure threshold. Centrally acting medicines require caution because dizziness and mental or motor impairment may overlap. Drowsiness, dizziness, reduced coordination and falls can be more likely. Driving and other hazardous tasks require particular caution when affected. The class warning does not mean that every combination is contraindicated or that each pair has been tested in a separate clinical trial. Concurrent antipsychotic treatment or a planned switch requires specialist review of movement symptoms, alertness, balance and cardiac risk. A class precaution is not evidence that all such combinations are absolutely contraindicated. Ask a pharmacist or prescriber to review the full medicine list before adding or changing treatment.
Using this information
This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.